Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Cancer Screening Molecular Tools

Fengting Yan

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024

J. Dominguez-Cherit

ASCO® 2024 Summary: "News in Head&Neck Cancers"

2024 ASCO® Annual Meeting Insights Hub

P. Bossi

GI and Hepatic Complications of Cancer Immunotherapy

Michigan Medicine

R. Fontana

Nasopharyngeal Carcinoma: Clinical Overview & Disease Management

Ammar Sukari

NOS ASCO® 2023 Review: Nasopharynx Cancer

Nebraska Oncology Society

E. Sherman

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

ESMO 2024 Summary: Head & Neck Cancer Take Home Messages

2024 ESMO Annual Meeting Insights Hub

P. Bossi

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL-IMMUNE &…

Insights from 2023 ASCO® Annual Meeting

P. Bossi

Incurable HPV- Head & Neck Cancer: Panel Discussion

GRACE

J. Weiss, S. Patel, S. Sheth

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Trials

2024 ASCO® Annual Meeting Insights Hub

K. Kerrigan

ASCO® 2024 Review: Updates on Metastatic HNSCC

Nebraska Oncology Society

E. Sherman

IFHNOS 2023 Insights: "Personalized (Precision) Medicine in Head and…

Insights from 2023 IFHNOS Annual Meeting

C. Stratakis

ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC…

2024 ESMO Annual Meeting Insights Hub

M. Tahara